comprehensive -WSS

comprehensive

author：fashion 2025-09-03 14:38:15 - browse：452

Boxes of Wegovy — pharma coverage from STAT — Carsten Snejbjerg/Bloomberg

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs.

Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. In turn, Novo Nordisk is buying three of Catalent’s fill-finish sites from the investment group for $11 billion. Novo Holdings manages the assets of the Novo Nordisk Foundation, which has a controlling stake in the pharmaceutical company.

Catalent has been involved in the production of Novo’s obesity treatment Wegovy. With the agreement, Novo will pick up sites that focus on filling drugs in Italy, Brussels, and Bloomington, Ind. All have already been doing work for Novo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

knowledge

focus

WSS

Drug companies' payments and gifts affect physicians' prescribing

Republican states more likely to report Covid vaccine side effects

Despite FDA concern, risk that CAR

Fetal surgery at risk from Dobbs and new abortion restrictions

Bird flu in dairy cattle: New measures to control spread to humans

Multiple sclerosis has subtypes with different best treatments: study

hotspot

comprehensive

entertainment

Virginia high school admissions case could be legal follow

How to pay for weight loss drugs and save Medicare

Psychedelics group wrestles with new pharma identity

Organ aging and disease risk measured by new blood test

Medical leaders decry Supreme Court decision on affirmative action

Flagship Pioneering launches a new biotech in two countries

The high cost of giving birth even with insurance

Will the market for weight loss drugs really reach $100 billion?

Guidelines to prevent youth baseball injuries need more muscle

Scientific mystery highlights the blind spots in genomics databases

entertainment

Insurer loopholes limit power of law against surprise medical bills

Bird flu reported in person exposed to presumably infected cattle

Florida Supreme Court upholds state's abortion ban

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Hundreds died while taking an arthritis drug, but nobody alerted patients

Mayo Clinic plans $5B tech

knowledge

focus

hotspot

hotspot